GLP Watchdog

Oak vs RxION Health

Neither Oak nor RxION Health has an FDA warning letter on record. On brand-name semaglutide pen, Oak costs $1,738 less a year at standing rates: $1,250 a month (billed every 4 weeks) against $1,499 a month at RxION Health. It is one of four products the two sell at comparable terms.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Oak / RxION Health

Featured pick (affiliate partner)

Oak logo

Oak

7.2/10

RxION Health logo

RxION Health

8.3/10

FDA warning letters
None on record
None on record
Pharmacy
None named in our record
None named in our record
Lowest standing price
$100/moBrand-name semaglutide pill, billed every 4 weeks
$149/moCompounded semaglutide injection
States
48 states
47 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit OakFull review
Visit RxION HealthFull review

Oak is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. RxION Health pays us nothing. The scores are computed the same way for both and are shown as computed (Oak 7.2, RxION Health 8.3). How we are paid

What the record shows

  1. 01

    Neither Oak nor RxION Health has an FDA warning letter on record.

  2. 02

    Neither names the pharmacy that compounds its medication.

  3. 03

    On brand-name semaglutide pen, Oak costs $1,738 less a year at standing rates: $1,250 a month (billed every 4 weeks) against $1,499 a month at RxION Health. It is one of four products the two sell at comparable terms.

  4. 04

    Only Oak lists a price for compounded oral semaglutide and brand-name semaglutide pill.

  5. 05

    Oak covers two states RxION Health does not and RxION Health covers one state Oak does not.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Oak

RxION Health

Compounded semaglutide injection

$250/mo

$3,000 a year

$149/moLower

$1,788 a year

Compounded tirzepatide injection

$300/mo

$3,600 a year

$199/moLower

$2,388 a year

Brand-name semaglutide pen

$1,250/moLower

$16,250 a year, 13 charges

$1,499/mo

$17,988 a year

Brand-name tirzepatide pen

$1,200/mo

$15,600 a year, 13 charges

$1,259/moLower

$15,108 a year

Compounded oral semaglutide

$260/mo

$3,380 a year, 13 charges

Not sold or not priced
Brand-name semaglutide pill

$100/mo

$1,300 a year, 13 charges

Not sold or not priced
Price includes
Medication, shipping, coaching
Medication, clinician visits, shipping
Cancel any time
Yes, stated
Yes, stated
Minimum term
None (3-, 6- and 12-month plans optional)
None on the monthly plan; prepaid plans cover 3 or 6 months
Refunds
No refunds once a provider approves the order
Medication portion refunded if not approved; the $75 consult fee and issued prescriptions are not refundable
Early-exit fee
Yes
None stated

Read off each seller’s own pages. Oak: October 17, 2026. RxION Health: October 17, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Oak

7.2/10
Featured pick (affiliate partner)
  • $1,738 a year less on brand-name semaglutide pen
  • Sells compounded oral semaglutide and brand-name semaglutide pill, which RxION Health does not price
  • Names no compounding pharmacy
Visit Oak

The case for RxION Health

8.3/10
  • $1,212 a year less on compounded semaglutide injection
  • $1,212 a year less on compounded tirzepatide injection
  • Names no compounding pharmacy
Visit RxION Health

Scores

Oak 7.2 · RxION Health 8.3 out of 10. Six weighted parts.

Value25%

3.1A
vs
B
7.1

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

7.5A
vs
B
7.5

Accessibility10%

9.7A
vs
B
9.5

Support10%

6.0A
vs
B
7.0

The score is the same formula for every seller. Payment does not enter it. Method

Oak vs RxION Health: questions

Neither Oak nor RxION Health has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Neither names the pharmacy that compounds its medication.
RxION Health, by $1,212 a year at standing rates. Oak: $250 a month, about $3,000 a year. RxION Health: $149 a month, about $1,788 a year.
Oak states you can cancel at any time; refunds: no refunds once a provider approves the order. RxION Health states you can cancel at any time; refunds: medication portion refunded if not approved; the $75 consult fee and issued prescriptions are not refundable.
Oak is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. RxION Health pays us nothing. The scores are computed the same way for both and are shown as computed (Oak 7.2, RxION Health 8.3).

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks